Panagora Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Panagora Asset Management’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.6M	Buy	+586,230	New	+$14.6M	0.06%	249
2019 Q2	–	Sell	-4,879	Closed	-$338K	–	2660
2019 Q1	$338K	Buy	+4,879	New	+$279K	﹤0.01%	1532
2015 Q2	–	Sell	-496	Closed	-$31K	–	2462
2015 Q1	$31K	Buy	+496	New	+$27.6K	﹤0.01%	2150
2014 Q4	–	Sell	-25,292	Closed	-$1.43M	–	2333
2014 Q3	$1.43M	Sell	25,292 -282	-1%	-$14.2K	0.01%	881
2014 Q2	$1.15M	Sell	25,574 -1,389	-5%	-$57.2K	0.01%	1055
2014 Q1	$1.32M	Buy	+26,963	New	+$1.39M	0.01%	1057

Other funds holding RARE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Panagora Asset Management's RARE Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 586,230 shares worth $19.6M. The stake represents 0.06% of the portfolio and ranks #249 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in RARE as recently as Q1 2019.

Panagora Asset Management first reported a position in RARE in Q1 2014 and has held it in 6 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

Panagora Asset Management held 586,230 shares of Ultragenyx Pharmaceutical worth $19.6M as of Q2 2026.
Ultragenyx Pharmaceutical was a new Panagora Asset Management position in Q2 2026.
Ultragenyx Pharmaceutical made up 0.06% of Panagora Asset Management's portfolio in Q2 2026, its #249 holding.
Panagora Asset Management first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 6 quarters since.
311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.